The record
Written from the 1 report below. Nothing here is unsourced.
- Claroid Pharma filed draft red herring prospectus papers with the market regulator for an upcoming initial public offering.
- The company intends to issue 1.26 crore equity shares to the public.
- Management plans to use the proceeds from the fresh issue to fund capital expenditure for a new manufacturing facility.
- This expansion will take place on land already owned by the company.
Coverage1
1 report
English national1
All filed from India
Named India · Claroid Pharma
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.